vedolizumab
takeda
[' vedo', 'vedo', 'crohn', 'vedolizumab']
geert d haens presented abstract that concluded that vedolizumab is highly effective to reduce the incidence and severity of postoperative endoscopy recurrence of crohn s disease. #ecco2023 . 
Coordinator of Gastroenterology - @HospitaldaBahia - Brazil. Taking care of IBD pt. since 2006. Passionate on medicine, teamwork and leadership.